What Does an OCT Scan Show in ADOA? | Inciteful Med

When your doctor looks at an Optical Coherence Tomography (OCT) scan to evaluate Autosomal Dominant Optic Atrophy (ADOA), they are looking for specific patterns of tissue loss in the nerve layers at the back of your eye. The test itself is painless, non-invasive, and only takes a few minutes (though you may or may not need your pupils dilated, depending on your clinic’s procedures). An OCT scan uses light waves to take highly detailed, cross-sectional pictures of your retina, acting much like an “optical ultrasound.”

In classic ADOA, a genetic mutation damages the mitochondria (the “energy factories”) inside your retinal ganglion cells—the vital cells that transmit visual information from the eye to the brain. The OCT scan can measure this microscopic damage, helping your doctor confirm your diagnosis, rule out other diseases, and track your condition over time.

Breaking Down the Clinical Terms

When reading your medical reports or discussing your OCT results, you will likely encounter several clinical terms describing the layers of your retina. Your doctor determines what is “thin” by comparing your specific numbers to a large database of healthy eyes of a similar age. Here is what your doctor is measuring:

• Retinal Nerve Fiber Layer (RNFL): This is the layer made up of the “wires” (axons) that travel from the ganglion cells in your retina to form the optic nerve. In ADOA, doctors specifically look for peripapillary RNFL thinning, which means the nerve fibers immediately surrounding the optic nerve head have degenerated or withered ^[1].
• Ganglion Cell Layer (GCL) and Ganglion Cell Complex (GCC): The ganglion cells are the main body of the nerve cells. Depending on your doctor’s software, they may measure the GCIPL (just the cell bodies and their connections) or the full GCC. The GCC includes three parts: the macular nerve fibers (RNFL), the cell bodies (GCL), and their connections (the inner plexiform layer). In ADOA, this complex is usually significantly thinner than normal ^[1][2]. Doctors consider the thickness of the macular GCC to be one of the most sensitive and critical “biomarkers” for ADOA ^[3]. This is because GCC thickness correlates strongly with functional visual outcomes—meaning it closely reflects how well you can actually see ^[3][4].

The Classic Pattern of Damage

ADOA does not damage the eye randomly; it leaves a very specific fingerprint on an OCT scan.

• Macular and Temporal Thinning: The macula is the center part of your retina, responsible for sharp, detailed, central vision. The cells in this area are highly vulnerable in ADOA. Your doctor will look for a signature pattern of thinning in this macular region ^[5][2].
• The Papillomacular Bundle: This is a specific dense bundle of nerve fibers connecting the macula directly to the temporal side of the optic nerve (the side of your eye closest to your ear). While damage is heavily concentrated here, an OCT scan typically reveals that the thinning in ADOA is widespread across the inner retinal layers, extending well beyond just this bundle to affect the entire central area of the retina (the posterior pole) ^[5][6].

Unique Features and “Microcysts”

In addition to thinning, the OCT scan might reveal other structural changes. In approximately 23% of people with ADOA, the scan may show macular microcystoid lacunae ^[7]. These are tiny, fluid-filled spaces or “cysts” that form within the inner layers of the retina.

These microcystic changes are most frequently observed in younger patients, those with a more noticeable reduction in visual acuity, and those who have more pronounced inner nerve fiber thinning ^[7]. While their exact cause is still being studied, they are a known feature of the disease and are thought to be spaces left behind by degenerated ganglion cells ^[7].

Why the OCT is a Crucial Tool

Understanding your OCT scan is empowering because it is the primary tool used to manage your care. Although visual function can sometimes remain relatively stable or reasonably good despite noticeable RNFL thinning ^[8], tracking these measurements over time is how your medical team monitors disease stability ^[4].

Furthermore, the specific map of tissue loss in ADOA looks very different from other conditions that cause optic nerve damage, such as normal-tension glaucoma (NTG) or Leber Hereditary Optic Neuropathy (LHON) ^[9][10]. Recognizing the distinct ADOA pattern on an OCT scan helps your doctor confirm your diagnosis accurately and ensures you do not receive unnecessary or incorrect treatments ^[9][10].